In conclusion, our study adds to the growing body of evidences that MLL-AF4, the oncogenic chimera typical of the t(4;11) ALL, promotes its aberrant transcriptional activity through the recruitment of nuclear molecular partners that, like FGFR2, consequently acquire an opportunistic oncogenic function. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.